Use of the Occlutech pmVSD Device for Hybrid Closure of a Large Mid-Muscular Ventricular Septal Defect in a Small Infant Born With Hypoplastic Aortic Arch-Reference-Cited by-同舟云学术

Use of the Occlutech pmVSD Device for Hybrid Closure of a Large Mid-Muscular Ventricular Septal Defect in a Small Infant Born With Hypoplastic Aortic Arch

Published:2023-09-26 Issue:1 Volume:15 Page:109-111
ISSN:2150-1351
Container-title:World Journal for Pediatric and Congenital Heart Surgery
language:en
Short-container-title:World J Pediatr Congenit Heart Surg

Author:

Minocha Prashant K.¹^ORCID,Caputo Massimo²,Ramroop Ronand³,Morgan Gareth J.¹^ORCID

Affiliation:

1. The Heart Institute, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, USA

2. Bristol Heart Institute, Bristol Royal Hospital for Children, University of Bristol, Bristol, UK

3. Division of Pediatric Cardiology, Department of Pediatrics, Eric Williams Medical Sciences Complex, University of the West Indies, Champ Fleurs, Trinidad and Tobago

Abstract

We describe the perventricular device closure of a large mid-muscular ventricular septal defect (VSD) in a 2.9 kg infant born with hypoplastic aortic arch and VSD using an Occlutech perimembranous occluder. In this case, the anatomy required a short low-profile device and hence a perimembranous occluder was used. To our knowledge, this is the first described use of this device for hybrid closure of a muscular VSD and the application of this technique in a patient <3 kg.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Pediatrics, Perinatology and Child Health,Surgery

Link

http://journals.sagepub.com/doi/pdf/10.1177/21501351231181107

Reference7 articles.

1. Transcatheter closure of ventricular septal defects.

2. Amplatzer Muscular VSD Occluder. https://www.accessdata.fda.gov/cdrh_docs/pdf4/p040040b.pdf.

3. Complete heart block associated with device closure of perimembranous ventricular septal defects

4. A Systematic Review on the Efficacy and Safety of Transcatheter Device Closure of Ventricular Septal Defects (VSD)

5. Occlutech® muscular ventricular septal defect device: the first reported human use